Bull case
BRO would need investors to value it at roughly 19x earnings — about 6x more generous than today's 12x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BRO stock could go
BRO would need investors to value it at roughly 19x earnings — about 6x more generous than today's 12x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 18x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 2x multiple contraction could push BRO down roughly 15% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Brown & Brown is a large insurance brokerage and risk management firm that connects clients with insurance carriers through its network of agents and brokers. It generates revenue primarily from commissions and fees earned by placing insurance policies across its four main segments—Retail (~50% of revenue), National Programs (~20%), Wholesale Brokerage (~20%), and Services (~10%). The company's competitive advantage lies in its decentralized, entrepreneurial culture that empowers local offices while leveraging national scale, along with deep industry specialization across various niche insurance programs.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.03/$0.99 | +4.5% | $1.2B/$1.3B | -2.3% |
| Q4 2025 | $1.05/$0.94 | +11.2% | $1.6B/$1.5B | +3.9% |
| Q1 2026 | $0.93/$0.91 | +2.8% | $1.6B/$1.6B | -2.6% |
| Q2 2026 | $1.39/$1.36 | +2.2% | $1.9B/$1.9B | +0.6% |
BRO beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $82 — implies +42.4% from today's price.
| Metric | BRO | S&P 500 | Financial Services | 5Y Avg BRO |
|---|---|---|---|---|
| Forward PE | 12.5x | 19.1x-34% | 10.5x+19% | — |
| Trailing PE | 17.9x | 25.2x-29% | 13.4x+34% | 27.2x-34% |
| PEG Ratio | 1.34x | 1.75x-23% | 1.03x+31% | — |
| EV/EBITDA | 12.7x | 15.3x-17% | 11.4x+11% | 18.1x-30% |
| Price/FCF | 13.9x | 21.3x-35% | 10.6x+31% | 22.1x-37% |
| Price/Sales | 3.2x | 3.1x | 2.3x+44% | 5.2x-38% |
| Dividend Yield | 1.10% | 1.88% | 2.68% | 0.66% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBRO posts 17.9% net margin with 9.3% ROE — the core signals of underwriting discipline and capital efficiency.
Premium revenue, margins, and returns
ROIC, leverage, and debt serviceability
Traditional FCF and debt/FCF ratios are not meaningful for financial companies. Focus on ROE and ROA above.
How capital is returned to owners
All figures from the trailing twelve months. For financial companies, ROE and ROA are the primary health signals — FCF-based metrics are not applicable.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
Brown & Brown's earnings are closely linked to the insurance pricing cycle. A softening market with declining premium rates can significantly slow revenue growth, as commissions are typically a percentage of premiums.
As an acquisitive company, Brown & Brown faces substantial risks related to the successful integration of mergers and acquisitions. Disruptions, cultural mismatches, and producer turnover can adversely affect performance and lead to increased costs.
Rising costs in wages, producer compensation, and technology, combined with slowing revenue growth, can lead to significant margin compression for Brown & Brown. This could negatively impact profitability and overall financial health.
Maintaining client retention and effective cross-selling are crucial for Brown & Brown's long-term growth. Increased competition or aggressive cost-cutting by clients could weaken retention and hinder organic growth.
Consolidation among insurance carriers may lead to demands for lower commissions or changes in distribution. This pressure could adversely affect Brown & Brown's revenue and profitability.
Operating in a heavily regulated environment exposes Brown & Brown to potential fines, litigation, or reputational damage. Compliance failures could result in significant financial penalties and operational disruptions.
There is a risk of customer loss and decreased margins due to competitors poaching employees from Brown & Brown. This could impact client relationships and overall business performance.
Shareholders of Brown & Brown have experienced dilution over the past year, which could affect their ownership percentage and overall returns. This dilution may raise concerns among investors regarding future capital raises.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Brown & Brown has consistently exceeded earnings per share (EPS) expectations, showcasing robust financial health. This strong performance underlines the company's ability to generate profits and maintain stability in a competitive market.
The company has demonstrated a notable year-over-year revenue increase, reflecting its expanding market presence in the insurance sector. This growth trajectory positions Brown & Brown favorably against its competitors.
Brown & Brown is poised to benefit from rising casualty rates and expanding opportunities across various insurance lines. Additionally, the company is well-positioned to take advantage of firming property rates in Florida, enhancing its market share.
The company has a strong history of consistent dividend increases, which underscores its financial stability and commitment to returning value to shareholders. This reliability can attract income-focused investors.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BRO BRO Brown & Brown, Inc. | $19.3B | 12.5x | +18.4% | 17.9% | Hold | +56.5% |
AJG AJG Arthur J. Gallagher & Co. | $50.6B | 14.9x | +19.3% | 10.7% | Buy | +39.3% |
MMC MMC Marsh & McLennan Companies, Inc. | $85.3B | 16.9x | +7.3% | 15.6% | Hold | +18.8% |
AON AON Aon plc | $66.0B | 16.2x | +6.6% | 22.5% | Buy | +31.2% |
WTW WTW Willis Towers Watson Public Limited Company | $23.8B | 12.9x | +2.3% | 16.8% | Buy | +34.1% |
RYA RYAN Ryan Specialty Holdings, Inc. | $3.8B | 13.8x | +19.1% | 4.2% | Buy | +55.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BRO returns 1.6% total yield, led by a 1.10% dividend, raised 32 consecutive years. Buybacks add another 0.5%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.34 | — | — | — |
| 2025 | $0.61 | +13.9% | 0.4% | 1.2% |
| 2024 | $0.54 | +13.7% | 0.2% | 0.7% |
| 2023 | $0.48 | +12.4% | 0.2% | 0.9% |
| 2022 | $0.42 | +11.2% | 0.8% | 1.5% |
Common questions answered from live analyst data and company financials.
Brown & Brown, Inc. (BRO) is rated Hold by Wall Street analysts as of 2026. Of 30 analysts covering the stock, 9 rate it Buy or Strong Buy, 21 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $89, implying +56.5% from the current price of $57. The bear case scenario is $48 and the bull case is $86.
The Wall Street consensus price target for BRO is $89 based on 30 analyst estimates. The high-end target is $89 (+57.4% from today), and the low-end target is $88 (+55.6%). The base case model target is $80.
BRO trades at 12.5x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals significantly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BRO in 2026 are: (1) Insurance Pricing Cycle — Brown & Brown's earnings are closely linked to the insurance pricing cycle. (2) Integration Execution — As an acquisitive company, Brown & Brown faces substantial risks related to the successful integration of mergers and acquisitions. (3) Margin Compression — Rising costs in wages, producer compensation, and technology, combined with slowing revenue growth, can lead to significant margin compression for Brown & Brown. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BRO will report consensus revenue of $7.6B (+18.4% year-over-year) and EPS of $4.07 (+20.1% year-over-year) for the upcoming fiscal year. The following year, analysts project $9.1B in revenue.
A confirmed upcoming earnings date for BRO is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Brown & Brown, Inc. (BRO) generated $1.5B in free cash flow over the trailing twelve months — a free cash flow margin of 23.0%. BRO returns capital to shareholders through dividends (1.1% yield) and share repurchases ($100M TTM).